3 Excellent ASX 200 Blue Chip Shares to Buy in May
If you are in the process of building an investment portfolio, then having a few ASX 200 blue chip shares in there could be a good starting point.
These ASX Stocks Could Rise 30% to 85%
If you're looking for some big returns to supercharge your portfolio, then read on.That's because analysts at Bell Potter have just put buy ratings on three ASX stocks and tipped them to rise between 30% and 90%.
CSL, LES EXPERTS EN CONNECTIVITÉ IOT CRITIQUE, SONT RAVIS D'ANNONCER LA NOMINATION DE GREVILLE COE AU POSTE DE DIRECTEUR COMMERCIAL
LONDRES, 3 mai 2024 /PRNewswire/ -- Greville Coe sera chargé de conduire la stratégie de croissance future de CSL autour de nouveaux marchés et de l'expansion géographique. M. Coe apporte à CSL
Exopharm Ltd Issues New Unlisted Options
Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP
Telix Pharmaceuticals (ASX:TLX) finalized the acquisition of QSAM Biosciences and its lead investigational drug Samarium-153-DOTMP, according to a Friday filing with the Australian Securities Exchange
Clarity Pharmaceuticals Target Price Raised 2.6% to A$4.00/Share by Bell Potter>CU6.AU
Clarity Pharmaceuticals Target Price Raised 2.6% to A$4.00/Share by Bell Potter>CU6.AU
lightfoot : junk, hook, line and sinker
Clueless Noob : great post. thank you for sharing
Christopher Flint197 : like to learn what a swing trade looks like and when to get in and out.